O-allylvanillin
O-allylvanillin is O-allylchalcone derivative with anti-cancer effects[1]. O-allylvanillin inhibits THP-1, HL60, Hep-G2, MCF-7 cells growth with IC50 values of 74.76 μM, 63.52 μM, 90.99 μM, and 90.11 μM, respectively[1].
Product Specifications
CAS Number
[22280-95-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H317, H319, H335
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others; Cancer
Assay Protocol
https://www.medchemexpress.com/o-allylvanillin.html
Concentration
10mM
Purity
98.41
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=CC1=CC=C(OCC=C)C(OC)=C1
Molecular Formula
C11H12O3
Molecular Weight
192.21
Precautions
H302, H315, H317, H319, H335
References & Citations
[1]B Ngameni, et al. Synthesis and evaluation of anticancer activity of O-allylchalcone derivatives. Med chem 2013, 3:3
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
AP2 Transcription Factor, alpha, beta (Clathrin Adaptor Protein Complex) (MaxLight 550) discontinued
KIFC1 (Kinesin-like Protein KIFC1, Kinesin-like Protein 2, Kinesin-related Protein HSET, HSET, KNSL2, MGC1202, MGC149736, MGC149737)
KIFC1 (Kinesin-like Protein KIFC1, Kinesin-like Protein 2, Kinesin-related Protein HSET, HSET, KNSL2, MGC1202, MGC149736, MGC149737)
